Siemens Healthineers announces first global installation of the Acuson Sequoia ultrasound system

Siemens Healthineers has announced the first global installation of its newest ultrasound system, the Acuson Sequoia, at Baptist Health South Florida. With ten facilities and five “centers of excellence” in the South Florida region, Baptist Health South Florida purchased numerous Acuson Sequoia systems in order to enhance its imaging capabilities within the scope of gastroenterology, primary care, and bariatric specialties. With its powerful architecture and innovative features, the new Acuson Sequoia expands precision medicine by enabling high-resolution imaging that adapts to patients’ size and personal physical characteristics, contributing to more confident diagnosis.

“The Acuson Sequoia enables our customers to image patients, regardless of size or body composition, with consistency and clarity,” says David Pacitti, President and Head of the Americas for Siemens Healthineers. “Without sacrificing image quality and potentially reducing the need for repeat scans and unclear diagnoses, the Acuson Sequoia will allow Baptist Health South Florida to underscore its commitment to clinical and service excellence in its community by improving the experiences of the patients it serves.”

Siemens Healthineers built the entirely new Acuson Sequoia system to adapt to the “BioAcoustic Variations” of each patient, characteristics that include tissue density, stiffness, and absorption. With its new Deep Abdominal Transducer (DAX), a new high-powered architecture, and innovative updates to elastography and contrast-enhanced ultrasound, the new Acuson Sequoia produces penetration up to 40cm without image quality degradation often caused by attenuating echo signals, an industry first.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.